STOCK TITAN

Esperion officer Koenig proposes $169K share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Esperion Therapeutics, Inc. (ESPR) officer and director Sheldon Koenig reported a proposed sale of 53,588 common shares, with an aggregate market value of $169,059.42 and an approximate sale date of June 17, 2026. He acquired the shares from the issuer through restricted stock vesting on June 16, 2026, as compensation. The notice states that the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. It lists 257,431,942 common shares outstanding. Koenig also reported a March 17, 2026 sale of 25,578 common shares for gross proceeds of $69,551.70. The notice was signed by Daniel Tucci, a duly authorized representative of Fidelity Brokerage Services LLC and attorney-in-fact for Koenig.

Shares reported for sale 53,588 common shares Approximate sale date June 17, 2026
Aggregate market value $169,059.42 Shares reported for sale
Common shares outstanding 257,431,942 shares Number outstanding listed in the notice
Shares acquired through restricted stock vesting 53,588 shares Acquired June 16, 2026, as compensation
Prior shares sold 25,578 common shares Sale dated March 17, 2026
Gross proceeds $69,551.70 Sale dated March 17, 2026
Restricted Stock Vesting financial
"Nature of Acquisition Transaction: Restricted Stock Vesting"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
vested equity award distribution financial
"settlement of a vested equity award distribution"
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Gross Proceeds financial
"Gross Proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ESPR shares did Sheldon Koenig report for sale?

Sheldon Koenig reported a proposed sale of 53,588 Esperion common shares, with an aggregate market value of $169,059.42 and an approximate sale date of June 17, 2026. The shares were acquired from the issuer through restricted stock vesting on June 16, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading